Parian, Adrian Rey M.
HRN: 22-26-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/27/2022
12/04/2022
IVTT
48mg
Q24
Omphalitis; PSNb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes